GOLD COAST - Anterior STEMI

–

Clinic Visit- 6 weeks after ACS

Atrial fibrillation + ACS

5 FOLD

–

What ’ s I mpor t ant ?

–

–

••

•

•

•

•

t i me…………

IMPROVE RISK

TRIPLE versus DOUBLE THERAPY –

WOEST Trial

Unanswer ed Q’ s

–

12 months

6 months

4 weeks

0

OAC, oral coagulation: either warfarin (INR: 2.0–2.5) or non-VKA OAC at lower tested dose in AF (dabigatran 110 mg BID, rivaroxaban 15 mg OD oapixaban 2.5 mg BID) *Dual therapy with oral anticoagulation and clopidogrel may be considered in selected patients; **ASA as an alternative to

2014 European guidance recommends a step-wise approach to individualize care

Time from PCI/ACS

Lifelong

12 months

6 months

4 weeks

0

OAC, oral coagulation: either warfarin (INR: 2.0–2.5) or non-VKA OAC at lower tested dose in AF (dabigatran 110 mg BID, rivaroxaban 15 mg OD oapixaban 2.5 mg BID) *Dual therapy with oral anticoagulation and clopidogrel may be considered in selected patients; **ASA as an alternative to

2014 European guidance recommends a step-wise approach to individualize care

Time from PCI/ACS

Lifelong

Dabigatran 110m

–

Optimal duration of DAPTafter ACS?

– –

Conclusion

THANK YOU